Evidence map›Paper›PMID 11148003›Full record

ReviewClinical microbiology reviews2001

Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.

J V Solnick, D B Schauer

Abstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed.

  1. Article
  2. Article
  3. Bacteremia caused byASM case reports · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in microbiology · 2024
    Review
  9. The effects and mechanisms of natural products onFrontiers in cellular and infection microbiology · 2024
    Review
  10. Article
  11. [Detection of Helicobacter species in humans and their dog]Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2023
    Article
  12. Population- and Gender-Based Investigation for Prevalence ofCanadian journal of gastroenterology & hepatology · 2023
    Article
  13. Article
  14. Pan-Genome-Assisted Computational Design of a Multi-Epitopes-Based Vaccine Candidate againstInternational journal of environmental research and public health · 2022
    Article
  15. Article
  16. Review
  17. The Role of Gut Microbiota in Gastrointestinal Tract Cancers.Archivum immunologiae et therapiae experimentalis · 2022
    Review
  18. Article
  19. Article
  20. Differentiation of GastricPathogens (Basel, Switzerland) · 2021
    Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

J V SolnickDepartment of Internal Medicine, Division of Infectious Diseases, University of California, Davis, California 95616, USA. jvsolnick@ucdavis.edu
D B Schauer

Funding

Gene expression during H. pylori-host interactionsR01AI042081 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI SOLNICK, JAY V. · 1998 to 2007
$2.5M
H. hepaticus: the pathogenesis of IBDR01DK052413 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SCHAUER, DAVID B · 1998 to 2007
$2.1M
Helicobacter hepaticus: pathogenesis of inflammatory bowel diseaseR56DK052413 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 2008 to 2008
$310k
NIAID NIH HHS AI42081NIAID NIH HHS R01 AI042081NIDDK NIH HHS DK52413NIDDK NIH HHS R01 DK052413NIDDK NIH HHS R56 DK052413
6 · The paper itself

Abstract

Since Helicobacter pylori was first cultivated from human gastric biopsy specimens in 1982, it has become apparent that many related species can often be found colonizing the mucosal surfaces of humans and other animals. These other Helicobacter species can be broadly grouped according to whether they colonize the gastric or enterohepatic niche. Gastric Helicobacter species are widely distributed in mammalian hosts and are often nearly universally prevalent. In many cases they cause an inflammatory response resembling that seen with H. pylori in humans. Although usually not pathogenic in their natural host, these organisms serve as models of human disease. Enterohepatic Helicobacter species are an equally diverse group of organisms that have been identified in the intestinal tract and the liver of humans, other mammals, and birds. In many cases they have been linked with inflammation or malignant transformation in immunocompetent hosts and with more severe clinical disease in immunocompromised humans and animals. The purpose of this review is to describe these other Helicobacter species, characterize their role in the pathogenesis of gastrointestinal and enterohepatic disease, and discuss their implications for our understanding of H. pylori infection in humans.

Indexed as

Disease Models, AnimalHelicobacter InfectionsAnimalsDigestive SystemFerretsGastrointestinal DiseasesHelicobacterHumansLiverMicroscopy, ElectronMicroscopy, Electron, ScanningMolecular Sequence DataRNA, Ribosomal, 16SRodentiaVirulenceRNA, Ribosomal, 16S

Identifiers

PMID11148003
PMCPMC88962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.